礼来公司表示,其糖尿病药物Zepbound(活性成分Tirzepatide)的Kwikpen注射笔,现可通过雇主福利平台,以统一优惠价449美元向网络内合作药房供货。该定价适用于所有剂量规格,旨在提升药品可及性。
礼来公司表示,其糖尿病药物Zepbound(活性成分Tirzepatide)的Kwikpen注射笔,现可通过雇主福利平台,以统一优惠价449美元向网络内合作药房供货。该定价适用于所有剂量规格,旨在提升药品可及性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.